SUDEEP PHARMA
Back to Balance Sheet
|
SUDEEP PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹49 Cr | ₹20 Cr | ₹25 Cr | ₹33 Cr | ₹19 Cr |
What is the latest Total Non-Current Liabilities ratio of SUDEEP PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹49 Cr |
| Mar2024 | ₹20 Cr |
| Mar2023 | ₹25 Cr |
| Mar2022 | ₹33 Cr |
| Mar2021 | ₹19 Cr |
How is Total Non-Current Liabilities of SUDEEP PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹49 Cr | 140.40 | |
| Mar2024 | ₹20 Cr | -19.93 | |
| Mar2023 | ₹25 Cr | -23.98 | |
| Mar2022 | ₹33 Cr | 79.02 | |
| Mar2021 | ₹19 Cr | - | |
Compare Total Non-Current Liabilities of peers of SUDEEP PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUDEEP PHARMA | ₹9,605.5 Cr | 0.1% | 22.1% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,803.0 Cr | 2.8% | 1.8% | 13.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,219.0 Cr | -0.2% | -0.1% | 3.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,417.0 Cr | 1.4% | -1.5% | 39.9% | Stock Analytics | |
| CIPLA | ₹116,116.0 Cr | 6% | 1.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,874.0 Cr | 4.8% | -0.3% | -0.9% | Stock Analytics | |
SUDEEP PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUDEEP PHARMA | 0.1% |
22.1% |
|
| SENSEX | -0.2% |
2.1% |
-5.6% |
You may also like the below Video Courses